Page last updated: 2024-10-29

ketoconazole and Cavernous Sinus Thrombophlebitis

ketoconazole has been researched along with Cavernous Sinus Thrombophlebitis in 1 studies

1-acetyl-4-(4-{[2-(2,4-dichlorophenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy}phenyl)piperazine : A dioxolane that is 1,3-dioxolane which is substituted at positions 2, 2, and 4 by imidazol-1-ylmethyl, 2,4-dichlorophenyl, and [para-(4-acetylpiperazin-1-yl)phenoxy]methyl groups, respectively.

Research Excerpts

ExcerptRelevanceReference
"Mucormycosis is an invasive fungal infection usually observed in immunocompromised patients."1.38Rhino-orbito-cerebral mucormycosis: five cases. ( Ben Brahim, H; Ben Romdhane, F; Chakroun, M; Hadhri, R; Harrathi, K; Koubaa, J; Larbi Ammari, F; Loussaief, C; Toumi, A, 2012)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Toumi, A1
Larbi Ammari, F1
Loussaief, C1
Hadhri, R1
Ben Brahim, H1
Harrathi, K1
Ben Romdhane, F1
Koubaa, J1
Chakroun, M1

Other Studies

1 other study available for ketoconazole and Cavernous Sinus Thrombophlebitis

ArticleYear
Rhino-orbito-cerebral mucormycosis: five cases.
    Medecine et maladies infectieuses, 2012, Volume: 42, Issue:12

    Topics: Acute Kidney Injury; Adult; Aged; Amphotericin B; Antifungal Agents; Biopsy; Cavernous Sinus Thrombo

2012